FCR AS FIRST LINE TREATMENT FOR PATIENTS WITHOUT COMORBIDITIES WITH CHRONIC LYMPHOCYTIC LEUKAEMIA: EXPERIENCE OF A CENTRE

被引：0
|
作者：
Juan Luis, Reguera Ortega [1 ]
Vadillo Irene, Sanchez [1 ]
Alvarez Teresa, De Soto [1 ]
Ortigueira Mar, Meijon [1 ]
Velandia Angelica, Martinez [1 ]
Martin Isabel, Goyanes [1 ]
Clemente Susan, Cortez [1 ]
Tello Patricia, Baltasar [1 ]
Yuste Victor, Jimenez [1 ]
Albendea Miguel, Canales [1 ]
机构：
[1] Hosp Univ La Paz, La Paz, Bolivia
来源：
HAEMATOLOGICA | 2016年 / 101卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PB-066
引用
收藏
页码：336 / 336
页数：1
相关论文
共 50 条
  • [1] IBRUTINIB IN CHRONIC LYMPHOCYTIC LEUKAEMIA: A SINGLE CENTRE EXPERIENCE
    Russell, J.
    Gomez, C.
    Bowles, K.
    Turner, G.
    Sadullah, S.
    [J]. HAEMATOLOGICA, 2015, 100 : 683 - 684
  • [2] 1st-line treatment with BR or FCR in patients with chronic lymphocytic leukaemia: First outcome data from the German prospective TLN Registry
    Knauf, W.
    Abenhardt, W.
    Engel, E.
    Grugel, R.
    Harde, J.
    Jaenicke, M.
    Marschner, N.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 50 - 50
  • [3] Fludarabine phosphate for the first-line treatment of chronic lymphocytic leukaemia
    Walker, S.
    Palmer, S.
    Erhorn, S.
    Brent, S.
    Dyker, A.
    Ferrie, L.
    Horsley, W.
    Macfarlane, K.
    White, S.
    Thomas, S.
    [J]. HEALTH TECHNOLOGY ASSESSMENT, 2009, 13 : 35 - 40
  • [4] COST EFFECTIVENESS ANALYSIS OF BENDAMUSTINE AS FIRST LINE TREATMENT FOR CHRONIC LYMPHOCYTIC LEUKAEMIA IN THE NETHERLANDS
    Vandekerckhove, S.
    Holtzer-Goor, K.
    Van Den Steen, D.
    van Megen, Y.
    Huijgens, P.
    Lamotte, M.
    Uyl-de Groot, C.
    [J]. VALUE IN HEALTH, 2012, 15 (07) : A425 - A425
  • [5] Fludarabine, cyclophosphamide and rituximab (FCR) in front line treatment of patients with chronic lymphocytic leukemia (CLL)
    Grifi, Fatiha
    Bougherira, Soraya
    Djenouni, Amel
    [J]. LEUKEMIA & LYMPHOMA, 2017, 58 : 94 - 94
  • [6] Experience with alemtuzumab in treatment of chronic lymphocytic leukaemia in the Netherlands
    Gorkom, B. A. P. Laros-van
    Huisman, C. A. M.
    Wijermans, P. W.
    Schipperus, M. R.
    [J]. NETHERLANDS JOURNAL OF MEDICINE, 2007, 65 (09): : 333 - 338
  • [7] Chronic lymphocytic leukaemia: current first-line therapy
    Carney, D. A.
    Mulligan, S. P.
    [J]. INTERNAL MEDICINE JOURNAL, 2009, 39 (01) : 44 - 48
  • [8] Safety and efficacy of rituximab based chemotherapy in chronic lymphocytic leukaemia patients: A single centre experience
    Gogia, A.
    Raina, V.
    Sharma, A.
    Kumar, L.
    [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 : S844 - S845
  • [9] FCR and Bevacizumab Treatment in Patients With Relapsed Chronic Lymphocytic Leukemia
    Jain, Preetesh
    Lee, Hun Ju
    Qiao, Wei
    Wierda, William
    Benjamini, Ohad
    Burger, Jan
    Ferrajoli, Alessandra
    Estrov, Zeev
    Kantarjian, Hagop
    Keating, Michael
    O'Brien, Susan
    [J]. CANCER, 2014, 120 (22) : 3494 - 3501
  • [10] Chemoimmunotherapy in the First-Line Treatment of Chronic Lymphocytic Leukaemia: Dead Yet, or Alive and Kicking?
    Smolej, Lukas
    Vodarek, Pavel
    Ecsiova, Dominika
    Simkovic, Martin
    [J]. CANCERS, 2021, 13 (13)
12345